These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22043581)

  • 1. Correction formula for creatinine concentration with glucose in dialysate.
    Kaitwatcharachai C; Kaitwatcharachai S; Wiriyasombat D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S135-9. PubMed ID: 22043581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucose interference in creatinine measurement using an enzymatic method: effect of creatinine concentrations.
    Kaitwatcharachai C; Kaitwatcharachai S; Aeden J; Wiriyasombat D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S131-4. PubMed ID: 22043580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations.
    Mak TW; Cheung CK; Cheung CM; Leung CB; Lam CW; Lai KN
    Nephrol Dial Transplant; 1997 Jan; 12(1):184-6. PubMed ID: 9027796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.
    Jeleniewicz R; Majdan M; Buraczyńska K; Portala P; Majdan M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):290-5. PubMed ID: 12898852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peritoneal equilibration test and results analysis in children undergoing chronic peritoneal dialysis].
    Yao Y; Chen Y; Yang JY; Huang JP; Xiao HJ; Liu JC
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):189-93. PubMed ID: 17504622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peritoneal equilibration test variables in pediatric CAPD patients.
    Fukuda M; Kawamura K; Okawa T; Kawahara K; Kamiyama Y; Honda M
    Acta Paediatr Jpn; 1994 Feb; 36(1):57-61. PubMed ID: 8165910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatinine excretion in continuous peritoneal dialysis: a systematic error of the Cockroft-Gault formula.
    Tzamaloukas AH; Murata GH
    Am J Kidney Dis; 2001 Oct; 38(4):862-6. PubMed ID: 11576892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine concentration measurement in glucose based peritoneal dialysate.
    Sjøland JA; Marcher KS
    Scand J Clin Lab Invest; 2003; 63(3):203-6. PubMed ID: 12817906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to assess efficacy of CAPD: preliminary results.
    Brandes JC; Piering WF; Beres JA
    Adv Perit Dial; 1990; 6():192-6. PubMed ID: 1982807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDH isoenzyme of the dialysate in noninfected PD patients.
    Suzuki K; Ishizaki M; Shishido Y
    Adv Perit Dial; 1997; 13():174-8. PubMed ID: 9360676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.